TSHA Market Cap & Key Metrics
Taysha Gene Therapies, Inc.
$4.45
+$0.02(+0.45%)
44
Overall
55
Value
27
Tech
50
Quality
Market Cap
$1.44B
Volume
2.41M
52W Range
$3.69 - $7.30
Target Price
$13.00
TSHA market cap is $1.44B. This page lists Taysha Gene Therapies, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
TSHA Key Metrics
- Market cap
- $1.44B
- EPS estimate, current year
- $-0.52
- EPS growth, 3-year
- +55.19%
- Value score
- 55
- Quality score
- 50
- Technical score
- 27
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $9.77M | $8.33M | $15.45M | $2.50M | - |
| EBITDA | -$106.43M | -$86.73M | -$104.11M | -$161.04M | -$172.60M |
| EPS | $-0.34 | $-0.36 | $-0.96 | $-3.78 | $-4.64 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TSHA | $4.45 | +0.5% | 2.41M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Taysha Gene Therapies, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW